Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Dilantin Side Effects Lawsuits | Side Effects: Stevens Johnson Syndrome, Life Threatening Skin Disease, Rashes, Skin Peeling, Sores On Mucous Membranes, Blistering Mucous Membranes

Dilantin Side Effects Have Been Associated With Stevens Johnson Syndrome Lawsuits

Dilantin | Lawsuits, Lawyers | Side Effects: Stevens Johnson Syndrome, Life Threatening Skin Disease, Rashes, Skin Peeling, Sores On Mucous Membranes, Blistering Mucous Membranes

Dilantin has been named in at least 100 lawsuits that claim the drug caused the serious and sometimes fatal skin reactions, Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis. It is expected that hundreds more Dilantin lawsuits could be filed in the future. Defendants include Pfizer, which makes the brand-name drug Dilantin, as well as generic drug makers like Mylan Pharmaceuticals and Baxter Healthcare. In October 2010, a lawsuit filed by the family of a 9 year-old girl, Jesse Nichols Jacobson, who died after taking Dilantin for less than a month, settled against Pfizer for $3.78 million.

Among other things, the Dilantin lawsuits claim that the U.S. Food and Drug Administration’s Adverse Event Reporting System, World Health Organization, and Health Canada Adverse Event Database all confirm reports of serious skin reactions in patients receiving Dilantin drug products. Plaintiffs allege the drug makers were aware of the drug’s dangers but failed to inform patients of risks.

Injured by Dilantin

Dilantin (Generic: Phenytoin) is an antiepileptic drug prescribed to manage temporal lobe seizures and grand mal seizures. The FDA approved Dilantin, manufactured by Pfizer, on November 20, 2001. A major side effect of Dilantin is a severe skin reaction called Stevens Johnson Syndrome (SJS), a severe allergic reaction to a drug. SJS is a potentially life threatening skin disease that causes rashes, skin peeling, sores on the mucous membranes and death.

With Stevens Johnson Syndrome (SJS), a person often encounters blistering of mucous membranes, typically in the mouth, eyes, and genitals. Nearly all cases are caused by a reaction to a drug, most often sulfa antibiotics, barbiturates, and anticonvulsants such as Dilantin. Stevens Johnson Syndrome (SJS) generally starts with a fever, headache, cough, and body aches, symptoms which may last from 1 to 14 days. Then a flat red rash breaks out on the face and trunk of the body, often spreading later to other parts of the body in an irregular pattern. The areas of rash enlarge and spread, often forming blisters. The skin of the blisters becomes very loose and easy to rub off. In addition, the damage to the lining of the mouth makes eating difficult. Closing of the mouth may be painful, so the person may drool. A person's eyes may swell and become so filled with pus that they seal shut. The corneas can become scarred. The opening through which urine passes (urethra) may also be affected, making urination difficult and painful. Sometimes the mucous membranes of the digestive and respiratory tracts are involved, resulting in diarrhea and difficulty breathing.

Other side effects associated with Dilantin include: confusion, constipation, discolored urine (pink, red, or brown), fatigue, slurred speech, agitation, anemia, bone marrow depression, chest discomfort, difficulty learning (children), dizziness, fever and chills, frequent bone fractures or breaks, headache, joint pain, light gray stools, low thyroid function, malformed bones, numbness or tingling in extremities (long-term use), painful erection, restlessness, severe stomach pain, severe skin reaction, shallow or troubled breathing, uncontrolled jerking of limbs, uncontrolled facial movements, unusual bleeding or bruising, weight loss, and yellow eyes or skin.

Legal Help For Victims Affected By Dilantin

If you or a loved one took Dilantin and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).


DilantinRSS Feed

Dilantin Side Effects Linked to Brain Atrophy

Jan 12, 2017
Dilantin is a drug taken by epileptic patients to control seizures. Dilantin has proven effective for many individuals who have not been helped by other medications. The anti-seizure medication is also prescribed off-label for conditions including bipolar disorder, depression, anxiety, and attention deficit hyperactivity disorder (ADHD). Unfortunately, there are some serious side effects with Dilantin (phenytoin) that affect the brain. These adverse effects may include cerebellar atrophy....

Anti-Seizure Medication, Dilantin, Tied to Episodes of Stevens Johnson Syndrome

Sep 12, 2016
Dilantin (phenytoin) is an anti-epilepsy drug sold by Pfizer Inc. and approved by the U.S. Food and Drug Administration (FDA) in 1938 to manage temporal lobe and grand mal seizures. Dilantin affects the brain's sodium channels, suppressing abnormal electrical activity. In addition to its other known adverse reactions, Dilantin has been associated with a serious, sometimes fatal skin reaction known as Stevens Johnson Syndrome (SJS). SJS often occurs as a severe allergic reaction to a medication...

Dilantin Linked to Cerebellar Atrophy

Sep 9, 2016
Dilantin (phenytoin) is a medication used to treat patients with epilepsy; it is manufactured by Pfizer. The U.S. Food and Drug Administration (FDA) has approved labeling changes to state that cerebellar atrophy has been reported in patients taking phenytoin. Cerebellar atrophy refers to the degeneration of the cerebellum, an area of the brain responsible for movement, balance, coordination, speech and other functions. Damage to the cerebellum can severely impair these functions. According to...

Dilantin Linked to Cerebellar Atrophy

Aug 4, 2016
Dilantin (phenytoin) is a medication used to treat epilepsy and is manufactured by Pfizer. Cases of cerebellar atrophy, a condition that affects the brain, have been reported in patients taking Dilantin. Cerebral atrophy occurs when there is degeneration of the cerebellum, an area of the brain responsible for movement, balance, and coordination. When the cerebellum suffers damage, the individual may experience unsteady gait, poor muscle control, trouble speaking or swallowing, and other...

Dilantin Injection Reportedly Causing Purple Glove Syndrome, FDA Says

Sep 9, 2008 | Parker Waichman LLP
Dilantin (Phenytoin) Injections Led to a Disorder Known as Purple Glove Syndrome According to a quarterly report it released last week, the Food & Drug Administration (FDA) is investigating instances were  Dilantin (phenytoin) injections led to a disorder known as Purple Glove Syndrome.  This condition, which was named for the discoloration that often accompanies it, can lead to the need for emergency surgery, and even limb amputation, if it becomes serious.Phenytoin is an...

More Dilantin News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo